GAP

A blood-based diagnostic test for neurodegenerative diseases is a global priority By Zivjena Vucetic 03/21/2025 As the global population ages, the incidence of neurodegenerative diseases such as Alzheimer’s disease (AD) is rapidly increasing. By 2050, the global population of people over the age of 60 is expected to double, reaching 2.1 billion individuals, while those over 80 […]

The Global Alzheimer’s Platform Foundation® (GAP) – which is focused on global game-changing dementia research working with the Scottish Funding Council’s Brain Health Alliance for Research Challenges (ARC)  proudly announces the first-of-its-kind Data Challenge Summit which will unveil the results stemming from the Bio-Hermes-001 Biomarker Data Challenge. The research competition was launched in February of 2024 to allow researchers early access […]

John Peters said the clinical trial he participated in at the Kawartha Centre gave him parts of his life back. John Peters wasn’t surprised when he started having trouble remembering things — he knew both his father and grandfather battled with Alzheimer’s. “The only big difference was I never smoked,” said Peters. “I was not […]

By Allie Corey Published  March 11, 2025 6:01pm EDT FOX 13 News Ironman athlete with Alzheimer’s sets a new goal FOX 13’s Allie Corey highlights Scott Berkheiser, who is inspiring others by competing in the Ironman Triathlon despite being diagnosed with early-onset Alzheimer’s at 55 years old. The Brief TAMPA, Fla. – The Ironman Triathlon is a grueling […]

By Katie Taranto; Published March 10, 2025 at 3:45PM A Dominion Hills woman diagnosed with early-onset Parkinson’s disease received national recognition last month for her advocacy work. Allison Signorelli was honored with the Citizen Scientist Cultivator Award for participating in various research trials after being diagnosed with the disease in 2022 at age 47. Signorelli has spent the […]

 International non-profit expands research network to Syracuse to improvecommunity access to research opportunities Washington D.C., Mar. 10, 2025- Global Alzheimer’s Platform Foundation® (GAP) announces the addition of Ichor Research, a leading private a clinical research organization based in Syracuse, New York, to its global network of over 100 best-in-class research sites. Specializing in neurodegenerative clinical trials, […]

GAP Citizen Scientist awards honor individuals’ contributions to research by Andrea Lobo | March 6, 202 A research advocate diagnosed with Parkinson’s disease and a former nurse with Alzheimer’s disease were among recipients of volunteer awards from the Global Alzheimer’s Platform Foundation (GAP).AGAP’s Citizen Scientist Awards acknowledge the contributions of volunteers in clinical trials for neurodegenerative diseases. Each year, GAP’s network of research sites, […]

The free clinical trial at Axiom Brain Health in Tampa works to detect early signs of Alzheimer’s and other cognitive diseases, even years before symptoms appear. Author: Hannah Dineen Published: 4:04 PM EST March 6, 2025 Updated: 8:52 PM EST March 6, 2025 TAMPA, Fla. — It’s estimated nearly 7 million people in the U.S. are living with Alzheimer’s disease. […]

Washington D.C., Feb. 18, 2025- The Global Alzheimer’s Platform Foundation ® (GAP) is gravely concerned over news of terminations of key leaders at the National Institute of Health and the Federal Drug Administration along with the firing of thousands of employees from the Department of Health and Human Services over the weekend. John Dwyer, the […]

Ralph Kern, MD, MHSc, CMO of Cognito Therapeutics, discusses scaling up clinical trials, integrating patient centricity and transitioning from therapeutics to device treatments. February 13, 2025 Tell us about the scientific foundation behind the Spectris ADTM device. Our non-invasive investigational Spectris ADTM device evokes 40 Hz brain gamma oscillations through audiovisual stimulation. It’s delivered in […]

Could a headset with flashing lights and sounds stimulate brain waves and treat Alzheimer’s? Cognito’s Phase 3 trial on such a device is trying to answer that question. Neuropsychologist Dr. Michelle Papka, the trial’s principal investigator and founder of the CRCNJ, explains the science. Researchers and technology companies are investigating whether non-invasive electromagnetic, visual, and […]

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for aging and longevity. Through a memorandum of understanding, the consortium, led by scholars from Harvard University, will gain early access to Bio-Hermes-001 data to investigate the potential for […]

January 30, 2025 10:24 PM in News – Local By: Lily Celeste The Rio Grande Valley has one of the highest rates of Alzheimer’s in the country, and a clinic in Rio Grande city is attempting to find out why. Dina Ximenez said she’s been volunteering for three years for Alzheimer’s studies conducted by El Faro Health Clinic […]

Collaboration to accelerate the investigation of Alzheimer’s disease biomarkers with early access to Bio-Hermes-001 data  Washington D.C., Jan. 30, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for aging and longevity. Through a memorandum […]

By Anjelica Rubin – Technology/Tampa Bay Inno reporter, Tampa Bay Business Journal Jan 27, 2025 Updated Jan 28, 2025 5:39pm EST Just over one year after being acquired to help build a clinical research center, Tampa-based Axiom Brain Health celebrated the next chapter in its neurodegenerative research at the launch of its new site on Jan. 23.  The expansion […]

Washington D.C., Jan. 27, 2025– Global Alzheimer’s Platform Foundation® (GAP) applauds the U.S. Food and Drug Administration (FDA)’s approval of IV maintenance dosing for the treatment LEQEMBI®. With this approval, after a patient completes 18 months of once every two weeks initiation phase, a transition to the maintenance dosing regimen of once every four weeks […]

Tampa, Fla. Jan. 24, 2025—Axiom Brain Health (Axiom) and the Global Alzheimer’s Platform Foundation® (GAP) celebrated the next chapter in neurodegenerative research at the launch of the newly renovated site on Thursday, January 23. The expansion of the research facility accommodates the growing need for more research of Alzheimer’s, Multiple Sclerosis, Parkinson’s, and other life-threatening […]

Washington D.C., Jan. 23, 2025 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002 study. This first-time collaboration will enhance this unique, observational platform study that compares blood-based and digital biomarkers across a broad range of clinical cognitive conditions, MRI and PET images […]

The Global Alzheimer’s Platform Foundation (GAP) is excited to announce its collaboration with Eli Lilly and Company on the transformative Bio-Hermes-002 study. This partnership is poised to broaden the understanding of Alzheimer’s disease by integrating advanced biomarkers that may assist in its early detection and diagnosis. Significance of the Bio-Hermes-002 Study Like its predecessor, Bio-Hermes-001, […]

Washington D.C., Dec. 9, 2024 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Eli Lilly and Company (Lilly) to the Bio-Hermes-002 study. This collaboration will enrich the unique, observational platform study that compares blood-based and digital biomarkers across a broad range of races and ethnicities that may help predict and diagnose Alzheimer’s […]

Washington D.C., Nov. 26, 2024- The Centers for Medicare & Medicaid Services (CMS) released the Clinical Laboratory Fee Schedule (CLFS) 2025 Final Rate Determinations yesterday, unveiling that clinically critical codes for the reimbursement of Alzheimer neurological biomarker blood tests have been referred to the process known as “gapfill.” Earlier this year, the preliminary recommendation for […]

By ActionNewsJax.com News Staff, November 18, 2024 at 5:32 pm EST Jacksonville Center for Clinical Research just joined the Global Alzheimer’s Platform Foundation’s national network of research centers. According to a news release, the JCCR has conducted more than 1,000 clinical trials over 25 years. Global Alzheimer’s Platform President John Dwyer said the organization wants to […]

Washington D.C., Nov. 18, 2024- Global Alzheimer’s Platform Foundation® (GAP) is welcoming a new clinical research site into its international network of best-in-class research sites, Jacksonville Center for Clinical Research of Jacksonville, Florida. Jacksonville Center for Clinical Research (JCCR) is a premier clinical research site, having conducted more than 1,000 clinical trials over 25 years with […]

Contify Life Science News Nov 3 • 11:52 PM *Cognivue’s participation in the study will help predict underlying AD pathologies and analyze MRI, neuroinflammation, and longitudinal data. Oct. 30– Cognivue issued the following news release:. Its proven ability to distinguish between cognitively normal individuals, those with MCI, and mild dementia— regardless of amyloid status., Validated […]